GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 111 filers reported holding GOSSAMER BIO INC in Q1 2023. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 200 | +98.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 101 | -99.8% | 0.00% | – |
| Q1 2023 | $52 | -98.3% | 41,580 | -97.1% | 0.00% | -100.0% |
| Q4 2022 | $3,109 | -99.8% | 1,432,620 | +838.5% | 0.00% | -50.0% |
| Q3 2022 | $1,830,000 | +4363.4% | 152,649 | +2965.9% | 0.00% | – |
| Q2 2022 | $41,000 | -97.5% | 4,979 | -96.6% | 0.00% | – |
| Q4 2021 | $1,638,000 | +1402.8% | 144,900 | +979.0% | 0.00% | – |
| Q2 2021 | $109,000 | +2080.0% | 13,429 | +2657.5% | 0.00% | – |
| Q1 2021 | $5,000 | -98.1% | 487 | -98.2% | 0.00% | – |
| Q4 2020 | $268,000 | -60.9% | 27,721 | -47.4% | 0.00% | -100.0% |
| Q2 2020 | $685,000 | +6750.0% | 52,714 | +5340.0% | 0.00% | – |
| Q1 2020 | $10,000 | – | 969 | +10666.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $1,447,000 | +2027.9% | 86,197 | +2646.9% | 0.00% | – |
| Q1 2019 | $68,000 | – | 3,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |